CD40LG and neoplasm: Furthermore, the expression of murine OX40L and CD40L from VALO-mD901 significantly increased the number of OVA antigen-specific T cells in tumors, as well as increased the number of OVA antigen-specific T cells in tumor-draining lymph nodes.